+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

COVID-19: TN govt gives consent to BCG trial at ICMR's Chennai institute

Jul 15, 2020, 14:16 IST
PTI
Chennai, Jul 15 () Sanction has been accorded to a trial by the Indian Council of Medical Research's Tuberculosis institute here to study the efficacy of BCG vaccine in the elderly in the fight against COVID-19, the government said on Wednesday.

Chief Minister K Palaniswami, in an order, has given the State's approval after ICMR sought Tamil Nadu government's permission to study the efficacy of the Bacillus Calmette- Gurin (BCG) vaccine in senior citizens at its National Institute for Research in Tuberculosis (NIRT) at Chetpet here,Health Minister C Vijayabaskar said.

Advertisement

"The ICMR's tuberculosis institute is set to begin the trial very soon," he said in a statement. He hoped that vaccinating the elderly with the time tested BCG would help reduce the intensity of COVID-19, admissions at hospitals and mortality rates. Describing the state's approval by Palaniswami for a trial here as among measures to protect people's welfare during the ongoing fight against COVID-19, Vijayabaskar said anti-viral measures will further be stepped up.

The NIRT under the ICMR is an internationally recognised institution for TB research. VGN ROH ROH

(This story has not been edited by www.businessinsider.in and is auto–generated from a syndicated feed we subscribe to.)
Next Article